Universal Vision Biotechnology Co., Ltd. (UNIVERSAL VISION BIOTECHNOLOGY ) Aktie

Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical instruments, eyeglasses, contact lenses, and eyeglass accessories. It is also involved in eyeglasses optometry and dispensing services and leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy analysis, as well as provides medical and scientific prescription eyeglasses. Further, it offers sunglasses, fashionable and reading glasses, and progressive lenses for presbyopia. Additionally, the company provides contact lenses for myopia, hyperopia, presbyopia, and astigmatism; Universal lutein supplements; Universal eyemall; and ortho-k and other products for myopia control. Further, it offers wholesale and retail of medical equipment, western medicine; purchase and sale of ophthalmic surgical investments, medical optical tool; corporate and medical project investment, therapeutic, and consulting services; ophthalmology clinics; healthcare investment management; and provides vision correction treatments, and operates a dispensing and retail business for eyeglasses. Additionally, the company provides various consulting services to partner clinics includes leasing, maintenance of ophthalmic equipment, procurement and sales of pharmaceuticals and consumables, business location assessment as well as store planning, IT integration and installment, brand marketing, and other professional administrative supports. Universal Vision Biotechnology Co., Ltd. was founded in 1992 and is based in Taipei, Taiwan.